Page last updated: 2024-08-22

megestrol and Invasiveness, Neoplasm

megestrol has been researched along with Invasiveness, Neoplasm in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, A; Ma, D; Yang, H; Yao, Y; Zhao, H	1
Schulder, M; Sharer, L; Vadivelu, S	1
Archer, SG; Barnes, D; Blamey, RW; Eliopoulos, A; Ellis, IO; Nicholson, RI; Robertson, JF; Spandidos, D	1

Reviews

1 review(s) available for megestrol and Invasiveness, Neoplasm

Article	Year
Hormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer: A case report and literature review. Medicine, 2017, Volume: 96, Issue:51 Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy, Needle; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Immunohistochemistry; Lung Neoplasms; Megestrol; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Assessment; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Hemorrhage	2017

Article

Year

Hormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer: A case report and literature review.

Medicine, 2017, Volume: 96, Issue:51

Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy, Needle; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Immunohistochemistry; Lung Neoplasms; Megestrol; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Risk Assessment; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Hemorrhage

2017

Other Studies

2 other study(ies) available for megestrol and Invasiveness, Neoplasm

Article	Year
Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy. Journal of neurosurgery, 2010, Volume: 112, Issue:5 Topics: Brain Neoplasms; Contraceptives, Oral, Synthetic; Female; Humans; Magnetic Resonance Imaging; Megestrol; Meningioma; Middle Aged; Neoplasm Invasiveness; Neurosurgical Procedures; Receptors, Progesterone; Time Factors	2010
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. British journal of cancer, 1995, Volume: 72, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53	1995

Article

Year

Regression of multiple intracranial meningiomas after cessation of long-term progesterone agonist therapy.

Journal of neurosurgery, 2010, Volume: 112, Issue:5

Topics: Brain Neoplasms; Contraceptives, Oral, Synthetic; Female; Humans; Magnetic Resonance Imaging; Megestrol; Meningioma; Middle Aged; Neoplasm Invasiveness; Neurosurgical Procedures; Receptors, Progesterone; Time Factors

2010

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.

British journal of cancer, 1995, Volume: 72, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; ErbB Receptors; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Goserelin; Humans; Ki-67 Antigen; Life Tables; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Nuclear Proteins; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Tumor Suppressor Protein p53

1995